Announcement

Collapse
No announcement yet.

3 Year Anniversary PSA

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • 3 Year Anniversary PSA

    Results from my 3 year Anniversary psa was 0.03 which is still considered undetectable by Mayo Clinic. Maybe have beat this or at least will stay undetectable for a loooong time.
    DOB 1955 63 at Dx
    3/2018 PSA 4.05 DRE Normal Refered to Uro PSA 10/2018 6.28
    Bx 11/2018 12 Cores 3 Pos 1-5% LM 2-50% LLB 3-50% LB
    GS 3+4=7 T1c Consult Mayo Clinic Phoenix Az 1/4/2019
    MRI w/Coil 2/27/2019 for surgery planning Mayo Az
    RALP 2/28/2019 Mayo Clinic Az Dr. Paul Andrews Recommend
    Path: GS 3+4=7 Tertiary Gleason Pattern none, Grade Group 2
    Tumor moderate to extensive volume mainly posterior portion of prostate
    Largest nodule measures 8mm
    Prostate: 21g 3.5x3x3 cm
    EPE: Neg - BNI: Neg - SVI: Pos Left SV - Margins: Pos LLB & CB 2mm focus each - LN Ex: 16 LN Involved 0 - Nerves Spared Right Side
    Path Staging pT3b pNO MX
    Continence: 99% at 9 wks - ED: Present
    PSA 4/17/19 < 0.10
    PSA 5/2/2019 < 0.007
    PSA 6/10/2019 < 0.10
    PSA 8/1/2019 < 0.007
    PSA 9/16/2019 < 0.10
    PSA 12/16/2019 < 0.10
    PSA 3/23/2020 < 0.007
    PSA 7/2/2020 < 0.007
    PSA 11/9/2020 0.064 uh-oh
    PSA 5/3/2021 < 0.10
    PSA 11/3/2021 <0.10
    PSA 4/29/2022 0.03

  • #2
    Congrats and hope you get that loooong time.
    YOB 1957

    DX 12/18, GS 8, 4+4 6/12 cores, LL Apex 100%, LM Apex 60%, LL Mid 50%, LMM 40%, LL Base 5%, LM &lt;5%, Right side negative.

    3/6/19. Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma
    T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate.
    7 Nodes, SV, SM, PNI, and BNI were negative.
    LVI and Cribriform pattern present.
    Decipher .86 High Risk.

    Post Surgery PSA
    3/25/19 .03. (25 days)
    4/25/19 <.03. (2 months)
    5/25/19 <.02 (3 months)
    9/10/2019. <.02 (7 months)
    11/27/2019. <.02. T < 3 (9 months)
    5/19/2020. <.02 (15 months)
    11/2/2020. <.02 (21 months)
    5/11/2021. <.02 T <3 (27 months)
    8/25/2021. <.02 T <3 (30 months)
    12/6/2021. <.02 T <3 (33 months)


    3 Part Modality Treatment Completed

    2/25/19 Robotic Laparoendoscopic Single Site Surgery outpatient Cleveland Clinic, Dr. Kaouk, surgery #41 in US.
    ART - 7/25/-9/25 2019 (78 Gy, yes, I glow in the dark).
    ADT - 5/19- 5/21 Eligard and Casodex.

    Comment


    • #3
      Congrats!
      EVen though I "graduated" to annual testing, I decided to have my annual physical and visit from surgeon 6 months apart, with each drawing PSA. That reduced my PSA anxiety a bit, and helped serve for a better baseline and earlier detection if my PSA did rise...
      BD: 1959 PSA 4.9 11/2012 (no symptoms)
      Biopsy 12/2012 Negative
      PSA 5.9 05/2013 (still no symptoms)
      Biopsy 6/2013 3+4 (thank goodness for PSA tests)
      1 core positive (upper left), 1 suspicious (lower left) out of 12
      DRE: bump right side T1c; PCA-III = 20 (normala)

      Da Vinci 7/18/2013:
      Total prostatectomy with seminal vesicles (S13-6085, 1-29, 7/18/13, 29 H&E and 1 paraffin block)
      Invasive carcinoma involves left lobe of prostate only, extends from left apex to posterior mid region of left lobe Gleason 7/10 (4+3); G4 tumor comprises 75% of invasive carcinoma present
      Estimated total volume of carcinoma in entire prostate gland: 10%
      TNM: T2b NX MX (Stage IIA)

      PSA History:
      8/13 11/13 2/14 8/14 2/15 8/15 3/16, 8/16, 3/17,9/17,4/18, 9/18 PSA "undetectable" (PSA <.1)

      March '19 = 0.1
      April '19 = 0.10 <-- switched to uPSA tests
      June '19 = 0.10
      Sept '19 = 0.10
      Dec '19 = 0.09
      Jan '20 = 0.13
      May '20 = 0.2 <- standard test by mistake
      Jun '20 = 0.11 <- back to uPSA test
      Aug '20 = 0.16
      Jan '21 = 0.23
      Feb '21 =0.20
      Mar '21 - started ADT/HT, radiation scheduled
      Jun '21 Eight Weeks Radiation @MSKCC
      Jul '21 <.05 (T-Level 0)
      Feb '22 <.05 (T-Level back to normal)

      Comment


      • #4
        I would choose 6-month testing, given that you are pT3b and that your last PSA did go up.

        Djin
        69 yr at diagnosis, BPH x 20 yr, 9 (!) negative biopsies, PCA3-
        7-05-13 TURP for BPH (90→30 g) path negative for PCa, then 6-mo. checks
        6-06-17 Nodule on right + PSA rise on finasteride: 3.6→4.3
        6-28-17 Bx #10: 2/14 cores: G10 (5+5) 50% RB, G9 (4+5) 3% RLM
        Nodule was negative for PCa
        Bone scan, CTs, X-rays: neg.
        8-7-17 Open RP, negative frozen sections, Duke Regional Hosp.
        SM EPE BNI LVI SVI LNI(5L, 11R): negative, PNI+, nerves spared
        pT2c pN0 pMX, G9 (4+5) acinar adenocarcinoma
        5% of prostate (4.5 x 5 x 4 cm, 64 g) involved
        Dry; ED OK with sildenafil
        11-10-17 Decipher score: 0.37, Low Risk:
        5-yr met risk: 2.4%, 10-yr PCa-specific mortality: 3.3%
        9-16-17 (5 wk) PSA <0.1
        LabCorp uPSA:
        11-28-17 (3 m ) 0.010
        02-26-18 (6 m ) 0.009
        05-30-18 (9 m ) 0.007 (nadir)
        08-27-18 (1 yr.) 0.018 (huh?)
        09-26-18 (13 m) 0.013 (retest)
        11-26-18 (15 m) 0.012
        02-25-19 (18 m) 0.015
        05-22-19 (21 m) 0.015
        08-28-19 (2 yr. ) 0.016
        12-18-19 (28 m) 0.015
        06-30-20 (34 m) <0.014
        12-30-20 (40 m) 0.037 (?)
        03-31-21 (43 m) 0.020
        07-13-21(46 m) 0.018
        01-25-22(52 m) 0.023

        Comment


        • #5
          Annual testing with SRT less than 24 months ago? 👎
          YOB 1957

          DX 12/18, GS 8, 4+4 6/12 cores, LL Apex 100%, LM Apex 60%, LL Mid 50%, LMM 40%, LL Base 5%, LM &lt;5%, Right side negative.

          3/6/19. Post surgery Pathology Report - Grade Group 4 Intraductal Carcinoma
          T3aNO, <1 mm non focal EPE, GS8, 21 mm uni-focal tumor involved 10% of prostate.
          7 Nodes, SV, SM, PNI, and BNI were negative.
          LVI and Cribriform pattern present.
          Decipher .86 High Risk.

          Post Surgery PSA
          3/25/19 .03. (25 days)
          4/25/19 <.03. (2 months)
          5/25/19 <.02 (3 months)
          9/10/2019. <.02 (7 months)
          11/27/2019. <.02. T < 3 (9 months)
          5/19/2020. <.02 (15 months)
          11/2/2020. <.02 (21 months)
          5/11/2021. <.02 T <3 (27 months)
          8/25/2021. <.02 T <3 (30 months)
          12/6/2021. <.02 T <3 (33 months)


          3 Part Modality Treatment Completed

          2/25/19 Robotic Laparoendoscopic Single Site Surgery outpatient Cleveland Clinic, Dr. Kaouk, surgery #41 in US.
          ART - 7/25/-9/25 2019 (78 Gy, yes, I glow in the dark).
          ADT - 5/19- 5/21 Eligard and Casodex.

          Comment


          • #6
            Djin my last one didn't go up.
            DOB 1955 63 at Dx
            3/2018 PSA 4.05 DRE Normal Refered to Uro PSA 10/2018 6.28
            Bx 11/2018 12 Cores 3 Pos 1-5% LM 2-50% LLB 3-50% LB
            GS 3+4=7 T1c Consult Mayo Clinic Phoenix Az 1/4/2019
            MRI w/Coil 2/27/2019 for surgery planning Mayo Az
            RALP 2/28/2019 Mayo Clinic Az Dr. Paul Andrews Recommend
            Path: GS 3+4=7 Tertiary Gleason Pattern none, Grade Group 2
            Tumor moderate to extensive volume mainly posterior portion of prostate
            Largest nodule measures 8mm
            Prostate: 21g 3.5x3x3 cm
            EPE: Neg - BNI: Neg - SVI: Pos Left SV - Margins: Pos LLB & CB 2mm focus each - LN Ex: 16 LN Involved 0 - Nerves Spared Right Side
            Path Staging pT3b pNO MX
            Continence: 99% at 9 wks - ED: Present
            PSA 4/17/19 < 0.10
            PSA 5/2/2019 < 0.007
            PSA 6/10/2019 < 0.10
            PSA 8/1/2019 < 0.007
            PSA 9/16/2019 < 0.10
            PSA 12/16/2019 < 0.10
            PSA 3/23/2020 < 0.007
            PSA 7/2/2020 < 0.007
            PSA 11/9/2020 0.064 uh-oh
            PSA 5/3/2021 < 0.10
            PSA 11/3/2021 <0.10
            PSA 4/29/2022 0.03

            Comment

            Working...
            X